share_log

RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $72

RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $72

RBC Capital将吉利德科学的板块绩效维持为Perform,将目标股价上调至72美元
Benzinga ·  08/09 15:25  · 评级/大行评级

RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and raises the price target from $71 to $72.

RBC Capital的分析师布莱恩·亚伯拉罕维持吉利德科学(纳斯达克:GILD)板块执行,将价格目标从71美元提高至72美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发